Cargando…
Association between P2Y12 inhibitor reloading and in-hospital outcomes for patients with non-ST-segment elevation acute coronary syndrome already on chronic P2Y12 receptor inhibitors therapy in China: findings from the CCC–ACS (improving care for cardiovascular disease in China-acute coronary syndrome) project
BACKGROUND: The association between P2Y12 receptor inhibitors reloading and in-hospital outcomes in non-ST-segment elevation acute coronary syndrome (NSTEACS) patients who were on chronic P2Y12 receptor inhibitors therapy remained underdetermined. METHODS: The Improving Care for Cardiovascular Disea...
Autores principales: | Wang, Yintang, Geng, Yu, Zhang, Ou, Xu, Qin, Xue, Yajun, Zhou, Boda, Zhang, Ping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893674/ https://www.ncbi.nlm.nih.gov/pubmed/36732830 http://dx.doi.org/10.1186/s40001-023-01025-6 |
Ejemplares similares
-
P2Y(12) Receptor Inhibitors in Acute Coronary Syndromes: What Is New on the Horizon?
por: Oprea, Adriana Dana, et al.
Publicado: (2013) -
De-escalation of P2Y12 Inhibitor Use After Percutaneous Coronary Intervention and Acute Coronary Syndromes
por: Barry, Quinton, et al.
Publicado: (2021) -
Ideal P2Y12 Inhibitor in Acute Coronary Syndrome: A Review and Current Status
por: Pradhan, Akshyaya, et al.
Publicado: (2022) -
P2Y12 Inhibitor Monotherapy with Clopidogrel versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention
por: Chen, Po-Wei, et al.
Publicado: (2020) -
Impact of body mass on P2Y12-inhibitor de-escalation in acute coronary syndromes—a substudy of the TROPICAL-ACS trial
por: Komócsi, András, et al.
Publicado: (2023)